{
    "status": "ok",
    "totalResults": 5,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Neuronetics",
            "title": "Neuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility",
            "description": "MALVERN, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help with the best neurohealth therap\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/03/2753772/0/en/Neuronetics-Draws-Down-Remaining-22-5-Million-Available-Under-Credit-Facility.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/12db9039-d4bf-41a0-8b4a-324398e392b4",
            "publishedAt": "2023-10-03T13:21:00Z",
            "content": "MALVERN, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever \u2026 [+5657 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "GREENBROOK TMS RAISES US$1.9 MILLION IN DEBT FINANCING",
            "description": "(marketscreener.com) \n\nTORONTO, Oct. 3, 2023 /PRNewswire/ - Greenbrook TMS Inc. today announced that it has received an aggregate of US$1.9 million in unsecured subordinated debt financing from certain new investors through the issuance and sale by the Compan\u2026",
            "url": "https://www.marketscreener.com/quote/stock/GREENBROOK-TMS-INC-47342203/news/GREENBROOK-TMS-RAISES-US-1-9-MILLION-IN-DEBT-FINANCING-44975871/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-10-03T20:31:06Z",
            "content": "TORONTO, Oct. 3, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) (\"Greenbrook\" or the \"Company\") today announced that it has received an aggregate of US$1.9 million in unsecured subordinated d\u2026 [+10077 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "GREENBROOK TMS RAISES US$1.9 MILLION IN DEBT FINANCING",
            "description": "TORONTO, Oct. 3, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) (\"Greenbrook\" or the \"Company\") today announced that it has received an aggregate of US$1.9 million in unsecured subordinated debt financing from certain new investors (the \"Investors\") t\u2026",
            "url": "https://www.prnewswire.com/news-releases/greenbrook-tms-raises-us1-9-million-in-debt-financing-301946304.html",
            "urlToImage": "https://mma.prnewswire.com/media/2238001/Greenbrook_TMS_Inc__GREENBROOK_TMS_RAISES_US_1_9_MILLION_IN_DEBT.jpg?p=facebook",
            "publishedAt": "2023-10-03T20:30:00Z",
            "content": "TORONTO, Oct. 3, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) (\"Greenbrook\" or the \"Company\") today announced that it has received an aggregate of US$1.9 million in unsecured subordinated d\u2026 [+9920 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Prophecy Market insights",
            "title": "Neuromodulation Market is estimated to be US$ 12.23 billion by 2030 with a CAGR of 8.9% during the forecast period \u2013 By PMI",
            "description": "Neuromodulation Market [2022-2030] Research Report Analysis and Outlook Insights | Latest Updated Report | The Neuromodulation Market research report analyses the global and regional markets, providing an in-depth analysis of the market's overall growth poten\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/28/2751553/0/en/Neuromodulation-Market-is-estimated-to-be-US-12-23-billion-by-2030-with-a-CAGR-of-8-9-during-the-forecast-period-By-PMI.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/20cb1ee4-d3e9-4331-b534-eae221b5f383",
            "publishedAt": "2023-09-28T17:00:00Z",
            "content": "Covina, Sept. 28, 2023 (GLOBE NEWSWIRE) -- What is Neuromodulation?\r\nNeuromodulation is an intracranial, electrical neuromodulation therapy that has FDA approval for the treatment for most of the neu\u2026 [+5576 chars]"
        },
        {
            "source": {
                "id": "politico",
                "name": "Politico"
            },
            "author": "By Hailey Fuchs",
            "title": "Colombia adds PR help",
            "description": "FGS Global registered with the Department of Justice as an agent of the Colombian government.",
            "url": "https://www.politico.com/newsletters/politico-influence/2023/09/15/colombia-adds-pr-help-00116379",
            "urlToImage": "https://static.politico.com/da/f5/44342c424c68b675719324b1106b/politico.jpg",
            "publishedAt": "2023-09-15T23:47:00Z",
            "content": "With Daniel Lippman\r\nCOLOMBIA SIGNS FGS:FGS Global registered with the Department of Justice as an agent of the Colombian government. The firm will provide public relations services around the U.S.-C\u2026 [+12479 chars]"
        }
    ]
}